Professor Paul G Overton

BA, PhD

School of Psychology

Professor of Neuroscience

Photo of Paul Overton
Profile picture of Photo of Paul Overton
P.G.Overton@sheffield.ac.uk
+44 114 222 6624
+44 114 276 6515 (fax)
Interdisciplinary Centre of the Social Sciences (ICOSS)

Full contact details

Professor Paul G Overton
School of Psychology
Interdisciplinary Centre of the Social Sciences (ICOSS)
219 Portobello
Sheffield
S1 4DP
Qualifications

BA, PhD (Sheffield)

Research interests

My research interests largely revolve around the Basal Ganglia (and related structures), a group of nuclei implicated in a wide range of normal brain processes and neurological/ psychiatric disorders. At present, there are three main strands to my work:

1. Attention Deficit Hyperactivity Disorder

2. Non-motor deficits in Parkinson’s disease

3. Emotion processing

Publications

Show: Featured publications All publications

Journal articles

  • Vautrelle N, Coizet V, Leriche-Vazquez M, Dahan L, Schultz J, Zhang Y-F, Zeghbib A, Overton P, Bracci E, Redgrave P & Reynolds J (2023) . Current Neuropharmacology, 22(9), 1513-1527.
  • Favila N, Gurney K & Overton PG (2023) . Journal of Psychopharmacology, 37(6), 610-626.
  • Overton P, Dommett E, Dinu L, Singh S, Baker N, Georgescu A & Singer B (2023) . Behavioral Sciences, 13(2).
  • Al Tannir R, Pautrat A, Baufreton J, Overton P & Coizet V (2023) . Current Neuropharmacology, 21(1), 22-30.
  • Vivas AB, Hussain-Showaiter SM & Overton PG (2021) . Applied Neuropsychology, 30(4), 447-457.
  • Riley T & Overton P (2019) . Medical Hypotheses, 133.
  • Tsatali M, Overton P & Vivas A (2019) . PLoS ONE, 14(10).
  • Panagiotidi M, Overton PG & Stafford T (2019) . Journal of Attention Disorders, 23(12), 1407-1415.
  • Pautrat A, Rolland M, Barthelemy M, Baunez C, Sinniger V, Piallat B, Savaster M, Overton PG, David O & Coizet V (2018) . eLife, 7.
  • Turner A, Kraev I, Stewart M, Stramek A, Overton PG & Dommett E (2018) . Neuropharmacology, 138, 118-129.
  • Turner A, Stramek A, Kraev I, Stewarts M, Overton PG & Dommett E (2018) . Journal of Psychopharmacology, 32(8), 949-954.
  • Panagiotidi M, Overton PG & Stafford T (2017) . Acta Psychologica, 181, 10-17.
  • Veltri T, Taroyan N & Overton PG (2017) . Journal of Psychopharmacology, 31(7), 861-872.
  • Garlovsky JK, Simpson J, Grunewald RA & Overton PG (2016) . Psychology & Health, 31(12), 1391-1414.
  • Brace LR, Kraev I, Rostron CL, Stewart MG, Overton PG & Dommett EJ (2015) . Neuroscience, 303, 364-377.
  • Powell PA, Simpson J & Overton PG (2015) . Body Image, 12, 98-107.
  • Overton PG, Vautrelle N & Redgrave P (2014) . Neuroscience, 282, 1-12.
  • Clements KM, Devonshire IM, Reynolds JNJ & Overton PG (2014) . Neuroscience, 274, 289-298.
  • Bertram C, Dahan L, Boorman LW, Harris S, Vautrelle N, Leriche M, Redgrave P & Overton PG (2014) . J Neurophysiol, 111(4), 755-767.
  • Rolland M, Carcenac C, Overton PG, Savasta M & Coizet V (2013) . NEUROSCIENCE, 252, 277-288.
  • Harris S, Bruyns-Haylett M, Kennerley A, Boorman L, Overton PG, Ma H, Zhao M, Schwartz TH & Berwick J (2013) . J Cereb Blood Flow Metab, 33(10), 1595-1604.
  • Powell PA, Simpson J & Overton PG (2013) . Cogn Emot, 27(5), 900-913.
  • Clements KM, Smith LM, Reynolds JNJ, Overton PG, Thomas JD & Napper RM (2012) . Neurophysiology, 1-11.
  • Delaney M, Leroi I, Simpson J & Overton PG (2012) Impulse Control Disorders in Parkinson's Disease: A Psychosocial Perspective. Journal of Clinical Psychology in Medical Settings, 1-9.
  • Comoli E, Das Neves Favaro P, Vautrelle N, Leriche M, Overton PG & Redgrave P (2012) . Front Neuroanat, 6, 9.
  • Devonshire IM, Papadakis NG, Port M, Berwick J, Kennerley AJ, Mayhew JEW & Overton PG (2012) . Neuroimage, 59(3), 1997-2006.
  • Lepora NF, Overton PG & Gurney K (2012) . J Comput Neurosci, 32(1), 1-24.
  • Lepora NF, Blomeley CP, Hoyland D, Bracci E, Overton PG & Gurney K (2011) . Eur J Neurosci, 34(9), 1390-1405.
  • Coizet V, Dommett EJ, Klop EM, Redgrave P & Overton PG (2010) . Neuroscience, 168(1), 263-272.
  • Dommett EJ, Overton PG & Greenfield SA (2009) . NEUROSCIENCE, 164(3), 1369-1376.
  • Coizet V, Graham JH, Moss J, Bolam JP, Savasta M, McHaffie JG, Redgrave P & Overton PG (2009) . J Neurosci, 29(17), 5701-5709.
  • Gowan JD, Coizet V, Devonshire IM & Overton PG (2008) . J Neural Transm (Vienna), 115(3), 377-387.
  • Overton PG, Markland FE, Taggart HS, Bagshaw GL & Simpson J (2008) . Emotion, 8(3), 379-385.
  • Devonshire IM, Mayhew JEW & Overton PG (2007) . Neuroscience, 146(2), 841-851.
  • Aked J, Coizet V, Clark D & Overton PG (2005) . Neuroscience, 134(2), 361-367.
  • Dommett E, Coizet V, Blaha CD, Martindale J, Lefebvre V, Walton N, Mayhew JEW, Overton PG & Redgrave P (2005) . Science, 307(5714), 1476-1479.
  • Devonshire IM, Berwick J, Jones M, Martindale J, Johnston D, Overton PG & Mayhew JEW (2004) . Neuroimage, 22(4), 1744-1753.
  • Comoli E, Coizet V, Boyes J, Bolam JP, Canteras NS, Quirk RH, Overton PG & Redgrave P (2003) . Nat Neurosci, 6(9), 974-980.
  • Lokwan SJ, Overton PG, Berry MS & Clark D (2000) . Neuroscience, 95(3), 647-656.

All publications

Edited books

  • Powell PA, Overton PG & Simpson J (Eds.) (2014) The Revolting Self: Perspectives on the Psychological, Social, and Clinical Implications of Self-Directed Disgust. Karnac Books.

Journal articles

  • Varbanov V, Overton PG & Stafford T (2025) . Frontiers in Psychology, 16.
  • Jackson EF, Riley TB & Overton PG (2025) . Journal of Neurodevelopmental Disorders, 17(20).
  • Al Tannir R, Pautrat A, Soutrenon R, Overton PG & Coizet V (2025) . European Journal of Neuroscience, 61(7).
  • Robson A, Ypsilanti A, Lazuras L, Powell PA, Overton PG & Reidy J (2025) . Journal of Affective Disorders, 369, 1256-1266.
  • Azlan HA-N, Overton PG & Dommett EJ (2025) . Advances in Neurodevelopmental Disorders, 9(1), 157-167.
  • Overton P, Dommett E, Dinu L, Singer B, Byrom N, Georgescu A-L & Singh S (2024) . Behavioural Brain Research, 461.
  • Coizet V, Al Tannir R, Pautrat A & Overton PG (2024) . Current Neuropharmacology, 22(9), 1473-1490.
  • Favila N, Gurney K & Overton P (2024) . Reviews in the Neurosciences, 35(1), 35-55.
  • Albesisi S & Overton PG (2023) . Advances in Neurodevelopmental Disorders, 8(4), 627-637.
  • Dinu LM, Singh SN, Baker NS, Georgescu AL, Overton PG & Dommett EJ (2023) . PLOS ONE, 18(11).
  • Aristotelidou V, Overton PG & Vivas AB (2023) . PLoS ONE, 18(8).
  • Vautrelle N, Coizet V, Leriche-Vazquez M, Dahan L, Schultz J, Zhang Y-F, Zeghbib A, Overton P, Bracci E, Redgrave P & Reynolds J (2023) . Current Neuropharmacology, 22(9), 1513-1527.
  • Pautrat A, Al Tannir R, Pernet-Gallay K, Soutrenon R, Vendramini E, Sinniger V, Overton P, David O & Coizet V (2023) . npj Parkinson's Disease, 9.
  • Adkins K, Overton PG, Moses J & Thompson AR (2023) . JMIR Dermatology, 6.
  • Favila N, Gurney K & Overton PG (2023) . Journal of Psychopharmacology, 37(6), 610-626.
  • Overton P, Dommett E, Dinu L, Singh S, Baker N, Georgescu A & Singer B (2023) . Behavioral Sciences, 13(2).
  • Varbanov V, Overton PG & Stafford T (2023) . Current Psychology, 42(36), 32355-32367.
  • Al Tannir R, Pautrat A, Baufreton J, Overton P & Coizet V (2023) . Current Neuropharmacology, 21(1), 22-30.
  • Rusakov DA, Giese KP, Sandi C, Dommett E & Overton PG (2022) . Neuropharmacology, 207, 108962-108962.
  • Vivas AB, Stournaras S, Paraskevopoulos A & Overton PG (2022) . Journal of Gambling Studies, 38(2), 635-652.
  • Panagiotidi M & Overton P (2022) . Current Psychology, 41(5), 2765-2771.
  • Aristotleidou V, Tsatali M, Overton P & Vivas A (2021) . PLoS ONE, 16(9).
  • Vivas AB, Hussain-Showaiter SM & Overton PG (2021) . Applied Neuropsychology, 30(4), 447-457.
  • Favila N, Gurney K & Overton P (2021) . Neuropharmacology, 196.
  • Panagiotidi M & Overton P (2021) . Journal of Psychopathology and Behavioral Assessment, 43(3), 559-564.
  • Overton PG & Coizet V (2020) . Medical Hypotheses, 144.
  • Panagiotidi M, Overton P & Stafford T (2020) . Psychiatry Research, 293.
  • Ypsilanti A, Gettings R, Lazuras L, Robson A, Powell P & Overton P (2020) . Frontiers in Psychology, 11.
  • Azlan H, Overton P, Simpson J & Powell P (2020) . Journal of Behavioral Medicine, 43(3), 377-390.
  • Janmohammadi S, Haghgoo HA, Farahbod M, Overton P & Pishyareh E (2020) . Journal of Eye Movement Research, 12(8).
  • Ypsilanti A, Robson A, Lazuras L, Powell P & Overton P (2020) . Journal of Affective Disorders, 266, 646-654.
  • Taroyan N, Butnicu B, Ypsilanti A & Overton P (2020) . Frontiers in Behavioral Neuroscience, 14.
  • Riley T & Overton P (2019) . Medical Hypotheses, 133.
  • Tsatali M, Overton P & Vivas A (2019) . PLoS ONE, 14(10).
  • Stafford T, Overton PG & Hampsey E (2019) . Journal of Eye Movement Research, 12(6).
  • Lazuras L, Ypsilianti A, Powell P & Overton PG (2019) . Motivation and Emotion, 43(1), 145-158.
  • Ypsilanti A, Lazuras L, Powell P & Overton PG (2019) . Journal of Affective Disorders, 243, 108-115.
  • Panagiotidi M, Overton PG & Stafford T (2019) . Journal of Attention Disorders, 23(12), 1407-1415.
  • Burden N, Simpson J, Murray C, Overton PG & Powell P (2018) . Body Image, 27, 109-117.
  • Panagiotidi M & Overton PG (2018) . Comprehensive Psychiatry, 87, 7-11.
  • Pautrat A, Rolland M, Barthelemy M, Baunez C, Sinniger V, Piallat B, Savaster M, Overton PG, David O & Coizet V (2018) . eLife, 7.
  • Turner A, Kraev I, Stewart M, Stramek A, Overton PG & Dommett E (2018) . Neuropharmacology, 138, 118-129.
  • Turner A, Stramek A, Kraev I, Stewarts M, Overton PG & Dommett E (2018) . Journal of Psychopharmacology, 32(8), 949-954.
  • Turner A, Stramek A, Kraev I, Stewart M, Overton PG & Dommett E (2018) . Behavioural Brain Research, 343.
  • Panagiotidi M, Overton PG & Stafford T (2018) . Comprehensive Psychiatry, 80, 179-185.
  • Azlan HA, Overton PG, Simpson J & Powell PA (2017) . Journal of Clinical Psychology in Medical Settings, 24(3-4), 355-364.
  • Panagiotidi M, Overton PG & Stafford T (2017) . Acta Psychologica, 181, 10-17.
  • Hetherington L, Dommett E, Turner A, Riley T, Haensel J & Overton PG (2017) . Journal of Psychopharmacology, 31(10), 1347-1361.
  • Buxton D, Bracci E, Overton PG & Gurney K (2017) . Frontiers in Computational Neuroscience, 11.
  • Veltri T, Taroyan N & Overton PG (2017) . Journal of Psychopharmacology, 31(7), 861-872.
  • Panagiotidi M, Overton P & Stafford T (2017) . Journal of Eye Movement Research, 10(1).
  • Panagiotidi M, Overton PG & Stafford T (2017) . Perception, 46(6), 665-678.
  • Azlan HA, Overton PG, Simpson J & Powell PA (2017) . Psychology and Health, 32(1), 19-37.
  • Garlovsky JK, Overton PG & Simpson J (2016) . Journal of Clinical Psychology, 72(10), 979-998.
  • Garlovsky JK, Simpson J, Grunewald RA & Overton PG (2016) . Psychology & Health, 31(12), 1391-1414.
  • Powell PA, Azlan HA, Simpson J & Overton PG (2016) . Journal of Behavioral Medicine, 39(4), 560-573.
  • Brace LR, Kraev I, Rostron CL, Stewart MG, Overton PG & Dommett EJ (2015) . Brain Research, 1629, 10-25.
  • Brace LR, Kraev I, Rostron CL, Stewart MG, Overton PG & Dommett EJ (2015) . Neuroscience, 303, 364-377.
  • Powell PA, Simpson J & Overton PG (2015) . Body Image, 12, 98-107.
  • Overton PG, Vautrelle N & Redgrave P (2014) . Neuroscience, 282, 1-12.
  • Harris S, Boorman L, Bruyns-Haylett M, Kennerley A, Ma H, Zhao M, Overton PG, Schwartz TH & Berwick J (2014) . Epilepsia, 55(9), 1423-1430.
  • Harris S, Ma H, Zhao M, Boorman L, Zheng Y, Kennerley A, Bruyns-Haylett M, Overton PG, Berwick J & Schwartz TH (2014) . Neuroimage, 97, 62-70.
  • Clements KM, Devonshire IM, Reynolds JNJ & Overton PG (2014) . Neuroscience, 274, 289-298.
  • Bertram C, Dahan L, Boorman LW, Harris S, Vautrelle N, Leriche M, Redgrave P & Overton PG (2014) . J Neurophysiol, 111(4), 755-767.
  • Powell PA, Overton PG & Simpson J (2013) . Journal of Clinical Psychology.
  • Rolland M, Carcenac C, Overton PG, Savasta M & Coizet V (2013) . NEUROSCIENCE, 252, 277-288.
  • Harris S, Bruyns-Haylett M, Kennerley A, Boorman L, Overton PG, Ma H, Zhao M, Schwartz TH & Berwick J (2013) . J Cereb Blood Flow Metab, 33(10), 1595-1604.
  • Powell PA, Simpson J & Overton PG (2013) . Cogn Emot, 27(5), 900-913.
  • Clements KM, Smith LM, Reynolds JNJ, Overton PG, Thomas JD & Napper RM (2012) . Neurophysiology, 1-11.
  • Delaney M, Leroi I, Simpson J & Overton PG (2012) Impulse Control Disorders in Parkinson's Disease: A Psychosocial Perspective. Journal of Clinical Psychology in Medical Settings, 1-9.
  • Comoli E, Das Neves Favaro P, Vautrelle N, Leriche M, Overton PG & Redgrave P (2012) . Front Neuroanat, 6, 9.
  • Devonshire IM, Papadakis NG, Port M, Berwick J, Kennerley AJ, Mayhew JEW & Overton PG (2012) . Neuroimage, 59(3), 1997-2006.
  • Lepora NF, Overton PG & Gurney K (2012) . J Comput Neurosci, 32(1), 1-24.
  • Siegal M, Fadda R & Overton PG (2011) . Philos Trans R Soc Lond B Biol Sci, 366(1583), 3427-3432.
  • Lepora NF, Blomeley CP, Hoyland D, Bracci E, Overton PG & Gurney K (2011) . Eur J Neurosci, 34(9), 1390-1405.
  • Simpson J, Hillman R, Crawford T & Overton PG (2010) . MOTIV EMOTION, 34(4), 399-406.
  • Coizet V, Dommett EJ, Klop EM, Redgrave P & Overton PG (2010) . Neuroscience, 168(1), 263-272.
  • Simpson J, Hillman R, Crawford T & Overton PG (2010) Self-esteem and self-disgust both mediate the relationship between dysfunctional cognitions and depressive symptoms. Motivation and Emotion, 1-8.
  • Redgrave P, Coizet V, Comoli E, McHaffie JG, Leriche M, Vautrelle N, Hayes LM & Overton P (2010) . Front Neuroanat, 4.
  • Dommett EJ, Overton PG & Greenfield SA (2009) . NEUROSCIENCE, 164(3), 1369-1376.
  • Coizet V, Graham JH, Moss J, Bolam JP, Savasta M, McHaffie JG, Redgrave P & Overton PG (2009) . J Neurosci, 29(17), 5701-5709.
  • Overton PG & Devonshire IM (2008) . Bioscience Hypotheses, 1(2), 70-77.
  • Gowan JD, Coizet V, Devonshire IM & Overton PG (2008) . J Neural Transm (Vienna), 115(3), 377-387.
  • Overton PG (2008) . Med Hypotheses, 70(6), 1121-1127.
  • Overton PG, Markland FE, Taggart HS, Bagshaw GL & Simpson J (2008) . Emotion, 8(3), 379-385.
  • Devonshire IM, Mayhew JEW & Overton PG (2007) . Neuroscience, 146(2), 841-851.
  • Simpson J, Anthony SH, Schmeer S & Overton PG (2007) . FOOD QUAL PREFER, 18(2), 183-189.
  • Coizet V, Overton PG & Redgrave P (2007) . J Comp Neurol, 500(6), 1034-1049.
  • Dommett EJ, Simpson J, Clark D & Overton PG (2007) . J Neural Transm (Vienna), 114(2), 161-172.
  • Simpson J, Carter S, Anthony SH & Overton PG (2006) . MOTIV EMOTION, 30(1), 31-41.
  • Coizet V, Dommett EJ, Redgrave P & Overton PG (2006) . Neuroscience, 139(4), 1479-1493.
  • McHaffie JG, Jiang H, May PJ, Coizet V, Overton PG, Stein BE & Redgrave P (2006) . Neuroscience, 138(1), 221-234.
  • Aked J, Coizet V, Clark D & Overton PG (2005) . Neuroscience, 134(2), 361-367.
  • Dommett E, Coizet V, Blaha CD, Martindale J, Lefebvre V, Walton N, Mayhew JEW, Overton PG & Redgrave P (2005) . Science, 307(5714), 1476-1479.
  • Berwick J, Devonshire IM, Martindale AJ, Johnston D, Zheng Y, Kennerley AJ, Overton PG & Mayhew JEW (2005) . Neuroscience, 132(2), 361-374.
  • Devonshire IM, Berwick J, Jones M, Martindale J, Johnston D, Overton PG & Mayhew JEW (2004) . Neuroimage, 22(4), 1744-1753.
  • Gurney KN & Overton PG (2004) . NEUROCOMPUTING, 58-60, 555-562.
  • Comoli E, Coizet V, Boyes J, Bolam JP, Canteras NS, Quirk RH, Overton PG & Redgrave P (2003) . Nat Neurosci, 6(9), 974-980.
  • Overton PG, Marrow LP, Brain PF & Clark D (2000) . Addict Biol, 5(3), 283-288.
  • Overton PG, Lokwan SJ, Berry MS & Clark D (2000) . J Neural Transm (Vienna), 107(12), 1381-1391.
  • Lokwan SJ, Overton PG, Berry MS & Clark D (2000) . Neuroscience, 95(3), 647-656.
  • Marrow L, Statham A, Overton PG, Brain PF & Clark D (1999) . Addict Biol, 4(1), 89-92.
  • Marrow LP, Overton PG, Brain PF & Clark D (1999) . Addict Biol, 4(4), 437-441.
  • Lokwan SJ, Overton PG, Berry MS & Clark D (1999) . Neuroscience, 92(1), 245-254.
  • Overton PG, Richards CD, Berry MS & Clark D (1999) . Neuroreport, 10(2), 221-226.
  • Marrow LP, Overton PG & Brain PF (1999) . Journal of Psychopharmacology, 13, 115-121.
  • Clark D & Overton PG (1998) Alterations in excitatory amino acid-mediated regulation of midbrain dopaminergic neurones induced by chronic psychostimulant administration and stress: relevance to behavioural sensitization and drug addiction. ADDICT BIOL, 3(2), 109-135.
  • Tong ZY, Overton PG, Martinez-Cué C & Clark D (1998) . Exp Brain Res, 118(4), 466-476.
  • Overton PG & Clark D (1997) . Brain Res Brain Res Rev, 25(3), 312-334.
  • Tong ZY, Overton PG & Clark D (1996) Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events.. Synapse, 22(3), 195-208.
  • Tong ZY, Overton PG & Clark D (1996) . J Neural Transm (Vienna), 103(8-9), 889-904.
  • Overton PG, Tong ZY & Clark D (1996) . J Neural Transm (Vienna), 103(5), 523-540.
  • Overton PG, Tong ZY, Brain PF & Clark D (1996) . Brain Res, 737(1-2), 146-154.
  • Overton PG, O'Callaghan JF & Greenfield SA (1995) . Exp Brain Res, 107(2), 151-165.
  • Tong ZY, Overton PG & Clark D (1995) . Brain Res, 674(1), 63-74.
  • Overton PG & Greenfield SA (1995) . Journal of Neural Transmission, 10, 41-54.
  • Marrow L, Overton P & Clark D (1993) Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat.. Behav Pharmacol, 4(1), 15-28.
  • Overton P & Clark D (1992) . Synapse, 10(2), 131-140.
  • Overton P, Elliott PJ, Hagan RM & Clark D (1992) . Eur J Pharmacol, 213(1), 165-166.
  • Overton P & Clark D (1992) . J Neural Transm Park Dis Dement Sect, 4(1), 1-14.
  • MARROW L, OVERTON P & CLARK D (1992) AMELIORATION OF SOME NEUROLEPTIC-INDUCED DEFICITS BY THE NMDA ANTAGONIST MK-801 IN A CONDITIONED REACTION-TIME-TASK. BEHAV PHARMACOL, 3(1), 57-64.
  • Redgrave P, Simkins M, overton P & Dean P (1992) . Neuroscience, 46(2), 379-390.
  • Overton P & Clark D (1991) . Eur J Pharmacol, 201(1), 117-120.
  • Overton P & Dean P (1988) . Behav Brain Res, 31(1), 1-15.
  • Overton P, Dean P & Redgrave P (1985) . Exp Brain Res, 59(3), 559-569.
  • Overton P, Dommett E, Chen T, Tawfig A-M & Fahmy L () Investigating the relationship between study-related factors and neurodivergent traits in undergraduate university students: an exploratory study. Neurodiversity.
  • Overton P, Dommett E, Panagiotidi M & Malaj A () Altered relationship between microsaccades and inattention in ADHD and the effects of stimulant medication. Advances in Neurodevelopmental Disorders.
  • Overton P, Jackson E & Riley T () The effect of 5-hydroxytryptophan, a serotonin precursor, on adults with high levels of Attention Deficit Hyperactivity Disorder traits: A randomised, controlled trial.. PLoS ONE.
  • Overton P, Luo J, Wu Y, Huang H, Xu G, Qi Y, Shao W, Zheng Y & He F () Comparing ADHD Symptom Network Structure in Chinese Youth with ADHD: ADHD Alone vs. ADHD with Comorbidities. Psychiatry Research.
  • Overton P & Varbanov V () Visual Orientation Discrimination in Adults With ADHD and ASD: The Differential Impact of Clinical Diagnosis and Trait Severity. Frontiers in Psychiatry.
  • Overton P, Luo J, Wen S, Wu Y, Huang H, Gaoyang X, Yanjie Q, Yi Z & Fan H () A Network Analysis of ADHD and ASD Symptoms in Chinese Children: Insights on Age and Gender Differences. International Journal of Methods in Psychiatric Research.
  • Overton P, Adkin K, Thompson A & Moses J () Unhelpful social media use? Investigating the role of upwards comparisons and self-compassion on stigma in people with acne. Frontiers in Medicine.
  • Gibson F, Overton P, Smulders T, Schultz S, Eglen S, Ingram C, Panzeri S, Bream P, Whittington M, Sernagor E , Cunningham M et al () . Nature Precedings.

Datasets

  • Aristotelidou V, Vivas A & Overton P .
  • Overton P, Powell P & Baiju S .
  • Varbanov V & Overton P .
  • Jackson E, Overton P & Riley T .
  • Varbanov V & Overton P .

Preprints

  • VARBANOV V, Overton P & Stafford T (2024) , Center for Open Science.
  • VARBANOV V, Overton P & Stafford T (2022) , Center for Open Science.
Research group

Grants

Current grants:

  • Title: Can a dysfunction of the basal ganglia and related low level nociceptive network underlie some central neuropathic pain symptoms in Parkinson’s disease? Coizet, V [PI], Baunez, C., Bandmann, O, Overton, P.G.Total funding (£): 573,868 Funding body: CoEN (MRC)

Past grants:

  • Overton, P.G. [PI], Gluing behaviours together - 'chunking' in the normal brain and its disruption in Parkinson's disease. Rosetrees Trust (£5450; 2018-2019)
  • Overton, P.G., Billington, T. [PI] Attention and behaviour: Transforming achievement and social inclusion following primary-secondary school transition. ESRC Collaborative studentship (£65.983; 2016-2020).
  • Overton, P.G,., Dommett, E.J. [PI], Singer, B., Byrom, N. Investigating the effects of cardio and non-cardio exercise on adults with Attention Deficit Hyperactivity Disorder. Rosetrees Trust (£59,282; 2019-2020).
Teaching activities

I am module organiser for PSY6306 (Fundamentals of Neuroscience).

PhD Opportunities

I am happy to receive applications for PhD study in my area of research.

We advertise PhD opportunities (Funded or Self-Funded) on 

For further information, please see the department PhD Opportunities page.

Links